Evidence map›Paper›PMID 26328059›Full record

ArticleOrganic chemistry frontiers : an international journal of organic chemistry2015

Syntheses of Sceptrins and Nakamuric Acid and Insights into the Biosyntheses of Pyrrole-Imidazole Dimers.

Xiaolei Wang, Yang Gao, Zhiqiang Ma, Rodrigo A Rodriguez, Zhi-Xiang Yu, Chuo Chen

Abstract read
In one paragraph

Article in Organic chemistry frontiers : an international journal of organic chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Total Synthesis of (±)-Sceptrin.Organic letters · 2020
    Article
  3. Article
  4. Natural products as inspiration for the development of new synthetic methods.Journal of the Chinese Chemical Society. Zhongguo hua xue hui (Taipei, Taiwan) · 2018
    Article
  5. Marine sponge alkaloids as a source of anti-bacterial adjuvants.Bioorganic & medicinal chemistry letters · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaolei WangDepartment of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Yang GaoCollege of Chemistry, Peking University, Beijing 100871, China ; Key Laboratory of Pesticide & Chemical Biology, Ministry of Education, College of Chemistry, Central China Normal University, Hubei, Wuhan 430079, China.
Zhiqiang MaDepartment of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Rodrigo A RodriguezDepartment of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
Zhi-Xiang YuCollege of Chemistry, Peking University, Beijing 100871, China.
Chuo ChenDepartment of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Funding

Asymmetric Synthesis of Biologically Active Marine Natural ProductsR01GM079554 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI CHEN, CHUO · 2007 to 2016
$2.9M
NIGMS NIH HHS R01 GM079554
6 · The paper itself

Abstract

Sceptrins and nakamuric acid are structurally unique antibiotics isolated from marine sponges. Recent studies suggest that the biosynthesis of these dimeric pyrrole-imidazole alkaloids involves a single-electron transfer (SET)-promoted [2+2] cycloaddition to form their cyclobutane core skeletons. We describe herein the biomimetic syntheses of racemic sceptrin and nakamuric acid. We also report the asymmetric syntheses of sceptrin, bromosceptrin, and dibromosceptrin in their natural enantiomeric form. We further provide mechanistic insights into the pathway selectivity of the SET-promoted [2+2] and [4+2] cycloadditions that lead to the divergent formation of the sceptrin and ageliferin core skeletons. Both the [2+2] and [4+2] cycloadditions are stepwise reactions, with the [2+2] pathway kinetically and thermodynamically favored over the [4+2] pathway. For the [2+2] cycloaddition, the dimerization of pyrrole-imidazole monomers is rate-limiting, whereas for the [4+2] cycloaddition, the cyclization is the slowest step.

Identifiers

PMID26328059
PMCPMC4551504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.